Cited by 77Mass Spectrometry Techniques and ApplicationsAdvanced Proteomics Techniques and ApplicationsMonoclonal and Polyclonal Antibodies Research

Direct Determination of Antibody Chain Pairing by Top-down and Middle-down Mass Spectrometry Using Electron Capture Dissociation and Ultraviolet Photodissociation

Open access
Shaw, Jared B., Liu, Weijing, Vasil′ev, Yury V., Bracken, Carter C., Malhan, Neha, Guthals, Adrian, Beckman, Joseph S., Voinov, Valery G.·2020·Analytical Chemistry

Abstract

One challenge associated with the discovery and development of monoclonal antibody (mAb) therapeutics is the determination of heavy chain and light chain pairing. Advances in MS instrumentation and MS/MS methods have greatly enhanced capabilities for the analysis of large intact proteins yielding much more detailed and accurate proteoform characterization. Consequently, direct interrogation of intact antibodies or F(ab')2 and Fab fragments has the potential to significantly streamline therapeutic mAb discovery processes. Here, we demonstrate for the first time the ability to efficiently cleave disulfide bonds linking heavy and light chains of mAbs using electron capture dissociation (ECD) and 157 nm ultraviolet photodissociation (UVPD). The combination of intact mAb, Fab, or F(ab')2 mass, intact LC and Fd masses, and CDR3 sequence coverage enabled determination of heavy chain and light chain pairing from a single experiment and experimental condition. These results demonstrate the potential of top-down and middle-down proteomics to significantly streamline therapeutic antibody discovery.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acs.analchem.9b03129

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The advancement of top-down proteomics is stimulated by commercial growth of large molecule therapeutics such as monoclonal antibodies and antibody-drug-conjugates, because detailed high-throughput characterization and quality control methods are required.

    “Undoubtedly, the advancement of top-down proteomics is stimulated by the commercial growth of large molecule therapeutics such as monoclonal antibodies and antibody-drug-conjugates as detailed and high-throughput methods for their characterization and quality control are required [81,159,160].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [18]Zubarev RA; Kruger NA; Fridriksson EK; Lewis MA; Horn DM; Carpenter BK; McLafferty FW J. Am. Chem. Soc 1999, 121 (12), 2857– 2862.
  2. [20]Gunawardena HP; Gorenstein L; Erickson DE; Xia Y; McLuckey SA Int. J. Mass Spectrom 2007, 265 (2–3), 130– 138.
  3. [21]Kalli A; Hakansson K Int. J. Mass Spectrom 2007, 263 (1), 71– 81.

Cited by

Sorted by citations

Authors
Shaw, J. B., Liu, W., Vasil′ev, Y. V., Bracken, C. C., Malhan, N., Guthals, A., Beckman, J. S., & Voinov, V. G.
Affiliations
  • Pacific Northwest National Laboratory (US)
  • e-MSion Inc., 2121 NE Jack London Drive, Corvallis, Oregon 97330, United States
  • Mapp Biopharmaceutical (United States) (US)
  • Oregon State University (US)
Corresponding author
Shaw, Jared B.
Venue
Analytical Chemistry
Published
2019-11-26
Volume
92
Issue
1
Pages
766-773
ISSN
  • 0003-2700 (ISSN-L)
  • 1520-6882
OpenAlex
W2989662178
Cited by
77
References
41
Citations by year
2026: 8 · 2025: 8 · 2024: 14 · 2023: 11 · 2022: 13 · 2021: 13 · 2020: 10
FWCI
3.59
Type
journal article
Language
en
Open access
Locations
  • Analytical Chemistry (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Biological and Environmental Research
  • National Institute of General Medical Sciences (R43GM122131-01, R44GM122131-02)
Topics
  • Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Monoclonal and Polyclonal Antibodies Research
Keywords
monoclonal antibodies, top-down mass spectrometry, middle-down mass spectrometry, electron capture dissociation, ultraviolet photodissociation, disulfide bond cleavage, F(ab')2 fragments, Fab fragment, antibody discovery, top-down proteomics
MeSH terms
Trastuzumab, Antineoplastic Agents, Immunological, Amino Acid Sequence, Antibodies, Monoclonal, Immunoglobulin Fab Fragments, Immunoglobulin Heavy Chains, Immunoglobulin Light Chains, Photolysis, Mass Spectrometry, Ultraviolet Rays

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review